XML 38 R27.htm IDEA: XBRL DOCUMENT v3.23.1
Earnings Per Share (Tables)
3 Months Ended
Mar. 31, 2023
Earnings Per Share [Abstract]  
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share
The table below sets forth the share-based awards that have been excluded from the computation of diluted earnings per share because their effect would be anti-dilutive:
 For the Three Months Ended March 31,
 20232022
Anti-Dilutive Options10,850 2,347,218 
Anti-Dilutive Restricted Stock Units484,301 2,493,698 
Anti-Dilutive Performance Share Units— 2,071,418 
495,151 6,912,334 
Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity The table below sets forth the share-based awards that have been exercised or released:
 For the Three Months Ended March 31,
 20232022
Options55,993 83,424 
Restricted Stock Units877,087 915,921 
Performance Share Units567,524 72,353 
1,500,604 1,071,698 
Schedule of Earnings Per Share, Basic and Diluted The computations for basic and diluted loss per share are as follows:
For the Three Months Ended March 31,
 20232022
Net Income (Loss)$710,395 $(922,941)
Basic Earnings (Loss) Available to Shareholders$710,395 $(922,941)
Effect of Dilutive Securities:
Add Back Interest on Convertible Notes (Net of Tax)$1,432 $— 
Diluted Earnings (Loss) Available to Shareholders$711,827 $(922,941)
Weighted-Average Shares of Common Stock Outstanding
168,452,107 199,854,257 
Effect of Diluted Shares:*
Options1,033,194 — 
Restricted Stock Units970,567 — 
Performance Share Units937,137 — 
Convertible Notes25,751,869 — 
Weighted-Average Diluted Shares of Common Stock Outstanding197,144,874 199,854,257 
Earning (Loss) per Share:
Basic$4.22 $(4.62)
Diluted$3.61 $(4.62)
*During periods in which the Company incurs a net loss, diluted weighted average shares outstanding are equal to basic weighted average shares outstanding because the effect of all equity awards and the potential share settlement impact related to CNX's Convertible Notes are antidilutive.